Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases

Detalhes bibliográficos
Autor(a) principal: Aldiane Gomes de Macedo Bacurau
Data de Publicação: 2018
Outros Autores: Priscila Maria Stolses Bergamo Francisco
Tipo de documento: Artigo
Idioma: eng
por
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866
Resumo: The objective was to estimate the prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases (CRDs). The sample included individuals 20 to 59 years of age (n = 23,329) and ≥ 60 years (n = 9,019) that participated in the Brazilian National Survey on Access, Utilization, and Promotion of Rational Use of Medicines (PNAUM) in 2013-2014. We estimated influenza vaccination prevalence rates and respective 95% confidence intervals (95%CI). Associations were verified with the Rao-Scott chi-square test, with significance set at 5%. For all adults and elderly with CRD, prevalence of vaccination was 42.1% (95%CI: 37.2-47.1), with a statistically difference between the two age groups (p < 0.001). The adult population showed significant differences according to marital status (p < 0.05), and the elderly population showed higher vaccination prevalence in the South of Brazil compared to the Northeast (p < 0.05). For the sample as a whole, chronic bronchitis was the most frequently reported disease (43.5%). Considering each specific disease, the percentage of vaccinated adults was low, varying from 25% (other respiratory diseases) to 42% (chronic bronchitis), without a statistically significant difference (p = 0.330). Individuals with respiratory diseases and the elderly in general (≥ 60 years) are priority groups for influenza vaccination; in general, in all the subgroups, prevalence rates were below the target set by the Brazilian Ministry of Health. The recommendation that the vaccine should be applied by a health professional may explain this low adherence to vaccination by the elderly.
id FIOCRUZ-5_6654a5ab91a7c96695aa1c2af918fb0d
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/6866
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseasesPrevalência de vacinação contra gripe nas populações adulta e idosa com doença respiratória pulmonar crônicaVaccinationHuman InfluenzaRespiratory Tract DiseasesAdultAgedVacinaçãoInfluenza HumanaDoenças RespiratóriasAdultoIdosoThe objective was to estimate the prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases (CRDs). The sample included individuals 20 to 59 years of age (n = 23,329) and ≥ 60 years (n = 9,019) that participated in the Brazilian National Survey on Access, Utilization, and Promotion of Rational Use of Medicines (PNAUM) in 2013-2014. We estimated influenza vaccination prevalence rates and respective 95% confidence intervals (95%CI). Associations were verified with the Rao-Scott chi-square test, with significance set at 5%. For all adults and elderly with CRD, prevalence of vaccination was 42.1% (95%CI: 37.2-47.1), with a statistically difference between the two age groups (p < 0.001). The adult population showed significant differences according to marital status (p < 0.05), and the elderly population showed higher vaccination prevalence in the South of Brazil compared to the Northeast (p < 0.05). For the sample as a whole, chronic bronchitis was the most frequently reported disease (43.5%). Considering each specific disease, the percentage of vaccinated adults was low, varying from 25% (other respiratory diseases) to 42% (chronic bronchitis), without a statistically significant difference (p = 0.330). Individuals with respiratory diseases and the elderly in general (≥ 60 years) are priority groups for influenza vaccination; in general, in all the subgroups, prevalence rates were below the target set by the Brazilian Ministry of Health. The recommendation that the vaccine should be applied by a health professional may explain this low adherence to vaccination by the elderly.El objetivo fue estimar la prevalencia de la vacunación contra la gripe en las poblaciones adultas y de la tercera edad con enfermedad respiratoria pulmonar crónica (DRPC). Se consideraron a individuos con edades entre 20 y 59 años (n = 23.329) y ≥ 60 años (n = 9.019) que participaron en la Encuesta Nacional sobre Acceso, Utilización y Promoción del Uso Racional de Medicamentos (PNAUM), realizada en 2013-2014. Se estimaron las prevalencias de vacunación contra la gripe y los respectivos intervalos del 95% de confianza (IC95%). Las asociaciones fueron verificadas por el test chi-cuadrado (Rao-Scott), considerándose un nivel de significancia de un 5%. Para el conjunto de los individuos con DRPC, la prevalencia de vacunación fue de un 42,1% (IC95%: 37,2-47,1), con una diferencia estadísticamente significativa, en relación con los grupos etarios (p < 0,001). Para la población adulta, se verificaron diferencias significativas respecto a la situación conyugal (p < 0,05), y para los ancianos, se observó una mayor prevalencia en el Sur, en comparación con el Nordeste (p < 0,05). Para el conjunto de los entrevistados, la bronquitis crónica fue la enfermedad más reportada (43,5%). Considerándose cada enfermedad específica, el porcentaje de adultos vacunados fue bajo, variando de un 25% (otras enfermedades pulmonares) a un 42% (bronquitis crónica), sin presentar una diferencia estadísticamente significativa (p = 0,330). Tanto los portadores de enfermedad pulmonar, como los ancianos en general (≥ 60 años), forman parte de grupos prioritarios para la vacunación contra la gripe y, de modo general, en todos los subgrupos considerados las prevalencias estuvieron por debajo de la meta establecida por el Ministerio de Salud. La recomendación de la vacuna por parte de los profesionales de salud puede contribuir a una mayor adhesión de ese grupo a la vacunación.O objetivo foi estimar a prevalência de vacinação contra gripe nas populações adulta e idosa com doença respiratória pulmonar crônica (DRPC). Foram considerados os indivíduos com idades entre 20 e 59 anos (n = 23.329) e ≥ 60 anos (n = 9.019) que participaram da Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM), realizada em 2013-2014. Estimaram-se as prevalências de vacinação contra gripe e os respectivos intervalos de 95% de confiança (IC95%). As associações foram verificadas pelo teste qui-quadrado (Rao-Scott), considerando-se um nível de 5% de significância. Para o conjunto dos indivíduos com DRPC, a prevalência de vacinação foi de 42,1% (IC95%: 37,2-47,1), com diferença estatisticamente significativa em relação aos grupos etários (p < 0,001). Para a população adulta, verificaram-se diferenças significativas em relação à situação conjugal (p < 0,05), e para os idosos, observou-se maior prevalência no Sul em relação ao Nordeste (p < 0,05). Para o conjunto dos entrevistados, bronquite crônica foi a doença mais referida (43,5%). Considerando-se cada doença específica, o percentual de adultos vacinados foi baixo, variando de 25% (outras doenças pulmonares) a 42% (bronquite crônica), sem apresentar diferença estatisticamente significativa (p = 0,330). Tanto os portadores de doença pulmonar quanto os idosos em geral (≥ 60 anos) fazem parte de grupos prioritários para a vacinação contra gripe e, de modo geral, para todos os subgrupos considerados, as prevalências estiveram abaixo da meta estabelecida pelo Ministério da Saúde. A recomendação da vacina pelos profissionais de saúde pode contribuir para uma maior adesão desse grupo à vacinação.Reports in Public HealthCadernos de Saúde Pública2018-05-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmltext/htmlapplication/pdfapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866Reports in Public Health; Vol. 34 No. 5 (2018): MayCadernos de Saúde Pública; v. 34 n. 5 (2018): Maio1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZengporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14876https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14877https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14878https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14879Aldiane Gomes de Macedo BacurauPriscila Maria Stolses Bergamo Franciscoinfo:eu-repo/semantics/openAccess2024-03-06T15:29:35Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/6866Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:07:51.897823Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
Prevalência de vacinação contra gripe nas populações adulta e idosa com doença respiratória pulmonar crônica
title Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
spellingShingle Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
Aldiane Gomes de Macedo Bacurau
Vaccination
Human Influenza
Respiratory Tract Diseases
Adult
Aged
Vacinação
Influenza Humana
Doenças Respiratórias
Adulto
Idoso
title_short Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
title_full Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
title_fullStr Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
title_full_unstemmed Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
title_sort Prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases
author Aldiane Gomes de Macedo Bacurau
author_facet Aldiane Gomes de Macedo Bacurau
Priscila Maria Stolses Bergamo Francisco
author_role author
author2 Priscila Maria Stolses Bergamo Francisco
author2_role author
dc.contributor.author.fl_str_mv Aldiane Gomes de Macedo Bacurau
Priscila Maria Stolses Bergamo Francisco
dc.subject.por.fl_str_mv Vaccination
Human Influenza
Respiratory Tract Diseases
Adult
Aged
Vacinação
Influenza Humana
Doenças Respiratórias
Adulto
Idoso
topic Vaccination
Human Influenza
Respiratory Tract Diseases
Adult
Aged
Vacinação
Influenza Humana
Doenças Respiratórias
Adulto
Idoso
description The objective was to estimate the prevalence of influenza vaccination in adults and elderly with chronic respiratory diseases (CRDs). The sample included individuals 20 to 59 years of age (n = 23,329) and ≥ 60 years (n = 9,019) that participated in the Brazilian National Survey on Access, Utilization, and Promotion of Rational Use of Medicines (PNAUM) in 2013-2014. We estimated influenza vaccination prevalence rates and respective 95% confidence intervals (95%CI). Associations were verified with the Rao-Scott chi-square test, with significance set at 5%. For all adults and elderly with CRD, prevalence of vaccination was 42.1% (95%CI: 37.2-47.1), with a statistically difference between the two age groups (p < 0.001). The adult population showed significant differences according to marital status (p < 0.05), and the elderly population showed higher vaccination prevalence in the South of Brazil compared to the Northeast (p < 0.05). For the sample as a whole, chronic bronchitis was the most frequently reported disease (43.5%). Considering each specific disease, the percentage of vaccinated adults was low, varying from 25% (other respiratory diseases) to 42% (chronic bronchitis), without a statistically significant difference (p = 0.330). Individuals with respiratory diseases and the elderly in general (≥ 60 years) are priority groups for influenza vaccination; in general, in all the subgroups, prevalence rates were below the target set by the Brazilian Ministry of Health. The recommendation that the vaccine should be applied by a health professional may explain this low adherence to vaccination by the elderly.
publishDate 2018
dc.date.none.fl_str_mv 2018-05-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866
dc.language.iso.fl_str_mv eng
por
language eng
por
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14876
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14877
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14878
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6866/14879
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
text/html
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 34 No. 5 (2018): May
Cadernos de Saúde Pública; v. 34 n. 5 (2018): Maio
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943387468955648

Registros relacionados